Pinheiro F, Pereira I, de Souza A, Mayrink Giardini H, Cordeiro R
Adv Rheumatol. 2024; 64(1):35.
PMID: 38702764
DOI: 10.1186/s42358-024-00374-y.
Trampert D, Kersten R, Tolenaars D, Jongejan A, van de Graaf S, Beuers U
JHEP Rep. 2024; 6(4):101015.
PMID: 38524667
PMC: 10959701.
DOI: 10.1016/j.jhepr.2024.101015.
Motta R, Culver E
Front Immunol. 2024; 15:1272084.
PMID: 38433835
PMC: 10904653.
DOI: 10.3389/fimmu.2024.1272084.
Schmidt P, Qasim A, Ali H, Bhatt V, Sulh M, Khaja M
Cureus. 2023; 15(7):e42475.
PMID: 37637516
PMC: 10450776.
DOI: 10.7759/cureus.42475.
Isoda A, Sairenji Y, Mihara M, Iriuchishima H, Saito A
Cureus. 2023; 15(6):e40620.
PMID: 37476122
PMC: 10354829.
DOI: 10.7759/cureus.40620.
A Review on The Role of Environmental Exposures in IgG4-Related Diseases.
Grasso C, Giacchero F, Crivellari S, Bertolotti M, Maconi A
Curr Environ Health Rep. 2023; 10(3):303-311.
PMID: 37314670
DOI: 10.1007/s40572-023-00401-y.
Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study.
Sun R, Liu Z, Lu H, Peng Y, Li J, Nie Y
RMD Open. 2023; 9(1).
PMID: 36759004
PMC: 9923356.
DOI: 10.1136/rmdopen-2022-002865.
The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review.
Dugic A, Verdejo Gil C, Mellenthin C, Vujasinovic M, Lohr J, Muhldorfer S
Biomedicines. 2022; 10(7).
PMID: 35884816
PMC: 9312496.
DOI: 10.3390/biomedicines10071511.
Exocrine and Endocrine Insufficiency in Autoimmune Pancreatitis: A Matter of Treatment or Time?.
Nikolic S, Maisonneuve P, Dahlman I, Lohr J, Vujasinovic M
J Clin Med. 2022; 11(13).
PMID: 35807009
PMC: 9267378.
DOI: 10.3390/jcm11133724.
[Studies on newly recognized chronic sialadenitis].
Yu G, Liu D, Li W, Hong X, Zhang Y, Zhu W
Beijing Da Xue Xue Bao Yi Xue Ban. 2022; 54(1):13-17.
PMID: 35165462
PMC: 8860657.
Autoimmune pancreatitis: What we know so far.
Masood M
JGH Open. 2022; 6(1):3-10.
PMID: 35071782
PMC: 8762623.
DOI: 10.1002/jgh3.12688.
Blue-collar work is a risk factor for developing IgG4-related disease of the biliary tract and pancreas.
Hubers L, Schuurman A, Buijs J, Mostafavi N, Bruno M, Vermeulen R
JHEP Rep. 2021; 3(6):100385.
PMID: 34816110
PMC: 8593662.
DOI: 10.1016/j.jhepr.2021.100385.
IgG4-related diseases of the digestive tract.
Lohr J, Vujasinovic M, Rosendahl J, Stone J, Beuers U
Nat Rev Gastroenterol Hepatol. 2021; 19(3):185-197.
PMID: 34750548
DOI: 10.1038/s41575-021-00529-y.
infection and other bacteria in pancreatic cancer and autoimmune pancreatitis.
Kunovsky L, Dite P, Jabandziev P, Dolina J, Vaculova J, Blaho M
World J Gastrointest Oncol. 2021; 13(8):835-844.
PMID: 34457189
PMC: 8371525.
DOI: 10.4251/wjgo.v13.i8.835.
Rapid deterioration of diabetes mellitus with morphological changes to the pancreas.
Yamamoto N, Dejima A
BMJ Case Rep. 2021; 14(2).
PMID: 33541986
PMC: 7868289.
DOI: 10.1136/bcr-2020-238878.
IgG4-related disease: Changing epidemiology and new thoughts on a multisystem disease.
Floreani A, Okazaki K, Uchida K, Gershwin M
J Transl Autoimmun. 2021; 4:100074.
PMID: 33490938
PMC: 7806798.
DOI: 10.1016/j.jtauto.2020.100074.
Management of primary sclerosing cholangitis and its complications: an algorithmic approach.
Prokopic M, Beuers U
Hepatol Int. 2020; 15(1):6-20.
PMID: 33377990
PMC: 7886831.
DOI: 10.1007/s12072-020-10118-x.
IgG4-related disease: a contemporary review.
Karadeniz H, Vaglio A
Turk J Med Sci. 2020; 50(SI-2):1616-1631.
PMID: 32777900
PMC: 7672352.
DOI: 10.3906/sag-2006-375.
Review of primary sclerosing cholangitis with increased IgG4 levels.
Manganis C, Chapman R, Culver E
World J Gastroenterol. 2020; 26(23):3126-3144.
PMID: 32684731
PMC: 7336326.
DOI: 10.3748/wjg.v26.i23.3126.
Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis.
Nikolic S, Brehmer K, Panic N, Valente R, Lohr J, Vujasinovic M
J Clin Med. 2020; 9(2).
PMID: 32028650
PMC: 7074280.
DOI: 10.3390/jcm9020409.
